Correction of hyperglycemia with a non-selective SGLT inhibitor, phlorizin, normalizes insulin sensitivity in partially pancreatectomized diabetic rats with moderate glucose intolerance [31] and non-insulin-dependent diabetic rats induced by neonatal streptozotocin [32]. The gene discussed is INS; the disease is Glucose intolerance.